Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03381274
Title Oleclumab (MEDI9447) EGFRm NSCLC Novel Combination Study
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors MedImmune LLC
Indications

lung non-small cell carcinoma

Therapies

AZD4635 + Oleclumab

Oleclumab + Osimertinib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.